ADP-ribosylation at R125 gates the P2X7 ion channel by presenting a covalent ligand to its nucleotide binding site

被引:106
作者
Adriouch, Sahil [1 ,3 ]
Bannas, Peter [1 ]
Schwarz, Nicole [1 ]
Fliegert, Ralf [2 ]
Guse, Andreas H. [2 ]
Seman, Michel [3 ]
Haag, Friedrich [1 ]
Koch-Nolte, Friedrich [1 ]
机构
[1] Univ Hamburg, Hosp Eppendorf, Ctr Diagnost, Inst Immunol, D-20246 Hamburg, Germany
[2] Univ Hamburg, Hosp Eppendorf, Inst Biochem & Mol Biol 1, D-20246 Hamburg, Germany
[3] Univ Rouen, Fac Med & Pharm, INSERM, U 519, Rouen, France
关键词
post-translational modification; purinoceptors; ADP-ribosyltransferases; leukocyte ecto-enzymes;
D O I
10.1096/fj.07-9294com
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ADP-ribosylation is a post-translational modification regulating protein function in which amino acid-specific ADP-ribosyltransferases (ARTs) transfer ADP-ribose from NAD onto specific target proteins. Attachment of the bulky ADP-ribose usually inactivates the target by sterically blocking its interaction with other proteins. P2X7, an ATP-gated ion channel with important roles in inflammation and cell death, in contrast, is activated by ADP-ribosylation. Here, we report the structural basis for this gating and present the first molecular model for the activation of a target protein by ADP-ribosylation. We demonstrate that the ecto-enzyme ART2.2 ADP-ribosylates P2X7 at arginine 125 in a prominent, cysteine-rich region at the interface of 2 receptor subunits. ADP-ribose shares an adenine-ribonculeotide moiety with ATP. Our results indicate that ADP-ribosylation of R125 positions this common chemical framework to fit into the nucleotide-binding site of P2X7 and thereby gates the channel.
引用
收藏
页码:861 / 869
页数:9
相关论文
共 53 条
  • [1] Probing the expression and function of the P2X7 purinoceptor with antibodies raised by genetic immunization
    Adriouch, S
    Dubberke, G
    Diessenbacher, P
    Rassendren, FO
    Seman, M
    Haag, F
    Koch-Nolte, F
    [J]. CELLULAR IMMUNOLOGY, 2005, 236 (1-2) : 72 - 77
  • [2] Cutting edge: A natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor
    Adriouch, S
    Dox, C
    Welge, V
    Seman, M
    Koch-Nolte, F
    Haag, F
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (08) : 4108 - 4112
  • [3] BOTULINUM-C2 TOXIN ADP-RIBOSYLATES ACTIN
    AKTORIES, K
    BARMANN, M
    OHISHI, I
    TSUYAMA, S
    JAKOBS, KH
    HABERMANN, E
    [J]. NATURE, 1986, 322 (6077) : 390 - 392
  • [4] AKTORIES K, 2000, BACTERIAL PROTEIN TO
  • [5] Activity and specificity of toxin-related mouse T cell ecto-ADP-ribosyltransferase ART2.2 depends on its association with lipid rafts
    Bannas, P
    Adriouch, S
    Kahl, S
    Braasch, F
    Haag, F
    Koch-Nolte, F
    [J]. BLOOD, 2005, 105 (09) : 3663 - 3670
  • [6] A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes
    Cabrini, G
    Falzoni, S
    Forchap, SL
    Pellegatti, P
    Balboni, A
    Agostini, P
    Cuneo, A
    Castoldi, G
    Baricordi, OR
    Di Virgilio, F
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (01) : 82 - 89
  • [7] Mutational analysis of the conserved cysteines of the rat P2X2 purinoceptor
    Clyne, JD
    Wang, LF
    Hume, RI
    [J]. JOURNAL OF NEUROSCIENCE, 2002, 22 (10) : 3873 - 3880
  • [8] Understanding the mode of action of diphtheria toxin: a perspective on progress during the 20th century
    Collier, RJ
    [J]. TOXICON, 2001, 39 (11) : 1793 - 1803
  • [9] Functional aspects of protein mono-ADP-ribosylation
    Corda, D
    Di Girolamo, M
    [J]. EMBO JOURNAL, 2003, 22 (09) : 1953 - 1958
  • [10] Inhibition of chlamydial infectious activity due to P2X7R-dependent phospholipase D activation
    Coutinho-Silva, R
    Stahl, L
    Raymond, MN
    Jungas, T
    Verbeke, P
    Burnstock, G
    Darville, T
    Ojcius, DM
    [J]. IMMUNITY, 2003, 19 (03) : 403 - 412